WallStreetZenWallStreetZen
Analyst Ranking
Bottom 9%
#4196 out of 4563 analysts
Average Return
-13.28%
Win Rate
27%9 out of 33
Risk vs Reward
Poor
Good

Jeff Garro's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Accolade IncACCD
+143.35%$5.56$13.53
2022-04-28 -
2023-04-28
Strong Buy
Nextgen Healthcare IncNXGN
+48.24%$16.15$23.94
2023-05-16 -
2023-11-08
Strong Buy
Nextgen Healthcare IncNXGN
+48.14%$16.16$23.94
2023-07-24 -
2023-11-08
Strong Buy
Nextgen Healthcare IncNXGN
+38.86%$17.24$23.94
2023-04-11 -
2023-11-08
Strong Buy
Cerner CorpCERN
+26.50%$72.75$92.03
2021-02-15 -
2022-02-15
Strong Buy

Jeff Garro Analyst Color

Get additional color on Jeff Garro's coverage of popular stocks

Jeff Garro's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Phreesia IncPHR
7Strong Buy$28.00+27.62%Reiterates
a month ago
Veradigm IncMDRX
6Hold$13.00+90.90%Reiterates
5 months ago
Trubridge IncTBRG
3Hold$14.00+76.77%Maintains
5 months ago
Certara IncCERT
4Strong Buy$20.00+21.58%Reiterates
6 months ago
Accolade IncACCD
5Strong Buy$18.00+91.49%Reiterates
7 months ago
Teladoc Health IncTDOC
2Hold$28.00+103.93%Reiterates
9 months ago
Nextgen Healthcare IncNXGN
3Strong Buy$24.00+0.25%Reiterates
9 months ago
Evolent Health IncEVH
2Strong Buy$40.00+36.71%Reiterates
a year ago
R1 Rcm IncRCM
1Strong Buy$18.00N/AInitiates Coverage On
a year ago
Privia Health Group IncPRVA
1Strong Buy$33.00N/AInitiates Coverage On
a year ago
Neuehealth IncNEUE
3Strong Buy$240.00N/AMaintains
2 years ago
Optimizerx CorpOPRX
2Hold$16.00N/AMaintains
2 years ago
Alignment Healthcare IncALHC
3Strong Buy$20.00N/AMaintains
2 years ago
Innovage Holding CorpINNV
2Strong Sell$3.90N/AMaintains
2 years ago
Selectquote IncSLQT
2Hold$3.00N/AMaintains
2 years ago
Iqvia Holdings IncIQV
1Strong Buy$255.00N/AUpgrades
2 years ago
Cerner CorpCERN
1Strong Buy$85.00N/AMaintains
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.